Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
2021 · Leukemia · 92 citations
https://doi.org/10.1038/s41375-021-01131-6
M
Manju Sengar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
374
Papers
4.6K
Citations
28
h-index
93
i10-index
Manju Sengar is an academic researcher from Homi Bhabha National Institute. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Acute Myeloid Leukemia Research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 28, co-authored 318 publications.
ORCID: 0000-0002-3509-5682Papers by this author
worksCancer care workforce in Africa: perspectives from a global survey
2019 · Infectious Agents and Cancer · 71 citations
https://doi.org/10.1186/s13027-019-0227-8
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward
2022 · The Lancet Global Health · 61 citations
https://doi.org/10.1016/s2214-109x(22)00376-x
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
2023 · Leukemia · 56 citations
https://doi.org/10.1038/s41375-023-01962-5
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials
2025 · The Lancet Oncology · 28 citations
https://doi.org/10.1016/s1470-2045(24)00451-0
A rare case of hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8
2018 · Cancer Genetics · 14 citations
https://doi.org/10.1016/j.cancergen.2018.06.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat